🔎 Trials Near Me

Início › Câncer de Pulmão de Não Pequenas Células › Distrito de Columbia

Ensaios clínicos de Câncer de Pulmão de Não Pequenas Células em Distrito de Columbia

38 estudos para Câncer de Pulmão de Não Pequenas Células estão buscando participantes em locais em Distrito de Columbia.

Cidades em Distrito de Columbia

Texto oficial do estudo (Inglês)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT04267848

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • Local Institution - 0183, Washington D.C.
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07680764

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

  • Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06472245

A Study of PHN-012 in Patients With Advanced Solid Tumors

  • PHN-012-001 Site, Washington D.C.
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07127874

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

  • Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital, Washington D.C.
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05498428

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • MedStar Georgetown University Hospital, Washington D.C.
  • Washington DC VA Medical Center, Washington D.C.
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06667076

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • Georgetown University, Washington D.C.
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07154290

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • Washington DC Veterans Affairs Medical Center, Washington D.C.
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06758401

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • MedStar Georgetown University Hospital, Washington D.C.
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT03191149

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

  • Sibley Memorial Hospital, Washington D.C.
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06890598

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

  • MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH), Washington D.C.
  • MEDSTAR Washington Hospital Center (MedStar Health Research Institute), Washington D.C.
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06712316

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Georgetown University Medical Center, Washington D.C.
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT05983432

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

  • George Washington University Cancer Center, Washington D.C.
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07195695

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • Georgetown University Lombardi Cancer Center, Washington D.C.
  • Sibley Memorial Hospital, Washington D.C.
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT05786924

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

  • Local Institution - 007-5476, Washington D.C.
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT04613596

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

  • MedStar Georgetown University Hospital (Lombardi Comprehensive Cancer Center), Washington D.C.
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT04302025

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Sibley Memorial Hospital, Washington D.C.
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06119581

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

  • Washington Hospital Center ( Site 0037), Washington D.C.
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06422143

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

  • MedStar Georgetown University Hospital, Washington D.C.
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT07288177

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

  • Sibley Memorial Hospital, Washington D.C.
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT06586515

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

  • Sibley Memorial Hospital, Washington D.C.
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT06500481

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

  • Georgetown University - Lombardi Comprehensive Cancer Center, Washington D.C.
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT07111520

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

  • Georgetown University Medical Center, Washington D.C.
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT06706076

Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features

  • Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT06449313

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

  • Georgetown University, Washington D.C.
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 21 de jul. de 2026 · NCT05098132

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

  • Georgetown University Medical Center, Washington D.C.
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de jun. de 2026 · NCT06162221

Gilteritinib for the Treatment of ALK NSCLC

  • Georgetown University, Washington D.C.
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 26 de jun. de 2026 · NCT06225427

Study of XB010 in Subjects With Solid Tumors

  • Georgetown University Medical Center, Washington D.C.
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 22 de jun. de 2026 · NCT06545331

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 3 de jun. de 2026 · NCT05642572

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

  • Georgetown University Medical Cener (GUMC), Washington D.C.
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 19 de mai. de 2026 · NCT07154706

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Research Site, Washington D.C.
RecrutandoFase 3
Idades de 18 a 130 · Todos os sexos · Atualizado em 14 de mai. de 2026 · NCT06417814

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
RecrutandoFase 2
18 Minutes · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT06031688

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • Sibley Memorial Hospital, Washington D.C.
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 13 de abr. de 2026 · NCT06810544

Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer

  • Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
  • Medstar Washington Hospital Center, Washington D.C.
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 16 de mar. de 2026 · NCT04499053

Repositioning Immunotherapy in VetArans With Lung Cancer

  • VA Central Office, Washington, DC, Washington D.C.
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de mar. de 2026 · NCT06275360

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • The George Washington University Cancer Center (site 212), Washington D.C.
RecrutandoFase 1/2
Idades de 18 a 80 · Todos os sexos · Atualizado em 11 de dez. de 2025 · NCT03556228

FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations

  • Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de jul. de 2025 · NCT06669117

Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.